Microbot Medical (MBOT) Scheduled to Post Quarterly Earnings on Friday

Microbot Medical (NASDAQ:MBOTGet Rating) is scheduled to be posting its quarterly earnings results on Friday, November 25th.

Microbot Medical Price Performance

Microbot Medical stock opened at $4.13 on Thursday. The business’s fifty day moving average is $4.51 and its two-hundred day moving average is $4.94. Microbot Medical has a 52 week low of $3.36 and a 52 week high of $9.60.

Hedge Funds Weigh In On Microbot Medical

Several large investors have recently made changes to their positions in MBOT. Cetera Advisor Networks LLC acquired a new position in shares of Microbot Medical during the first quarter valued at $78,000. Renaissance Technologies LLC lifted its stake in shares of Microbot Medical by 52.5% during the first quarter. Renaissance Technologies LLC now owns 15,695 shares of the biotechnology company’s stock valued at $98,000 after acquiring an additional 5,400 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in shares of Microbot Medical by 4.1% during the third quarter. Dimensional Fund Advisors LP now owns 92,451 shares of the biotechnology company’s stock valued at $442,000 after acquiring an additional 3,609 shares during the period. Institutional investors and hedge funds own 9.90% of the company’s stock.

Microbot Medical Company Profile

(Get Rating)

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio.

Featured Articles

Earnings History for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.